Osaka, Japan

Yoshio Ohba



Average Co-Inventor Count = 8.7

ph-index = 1


Location History:

  • Tokushima, JP (2015)
  • Osaka, JP (2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yoshio Ohba in Vaccine Development

Introduction

Yoshio Ohba is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of vaccine development, particularly through his innovative work on recombinant baculovirus vaccines. With a total of 3 patents to his name, Ohba's inventions are aimed at addressing infectious diseases such as malaria and influenza.

Latest Patents

One of Yoshio Ohba's latest patents focuses on a recombinant baculovirus vaccine. This invention provides a novel transfer vector and a recombinant baculovirus, along with methods for their production. The pharmaceuticals developed from this recombinant baculovirus serve as preventive or therapeutic drugs for infectious diseases. More specifically, the invention includes a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter. The methods outlined in this patent detail how to prevent and treat infectious diseases by administering the recombinant baculovirus to patients.

Career Highlights

Throughout his career, Yoshio Ohba has worked with notable organizations, including the Educational Foundation Jichi Medical University and Otsuka Pharmaceutical Company, Limited. His work in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Yoshio Ohba has collaborated with esteemed colleagues such as Shigeto Yoshida and Masanori Kawasaki. These partnerships have further enriched his research and have played a crucial role in the success of his inventions.

Conclusion

Yoshio Ohba's contributions to vaccine development through his innovative patents highlight his commitment to addressing global health challenges. His work continues to pave the way for advancements in the prevention and treatment of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…